RADIOTHERAPY AND ICRF 159 (NSC 129 943) IN TREATMENT OF INOPERABLE SOFT-TISSUE SARCOMA

被引:7
作者
RHOMBERG, W
HELLMANN, K
RYALL, RDH
机构
[1] MED HSCH HANOVER,ABT STRAHLENTHERAPIE & SPEZIELLE ONKOL,KARL-WIECHERT ALLEE 9,3 HANOVER,WEST GERMANY
[2] MED HSCH HANOVER,DEPT KLIN RADIOL,3 HANOVER,WEST GERMANY
[3] IMPERIAL CANC RES FUND,CANC CHEMOTHERAPY DEPT,LONDON,ENGLAND
[4] CLATTERBRIDGE HOSP W,LIVERPOOL REG RADIOTHERAPY CTR,BEBINGTON,CHESHIRE,ENGLAND
关键词
D O I
10.1055/s-0028-1108151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2438 / &
相关论文
共 24 条
[1]  
BELLET RE, 1973, CANCER CHEMOTH REP 1, V57, P185
[2]   COMBINATION THERAPY WITH DRUGS AND RADIATION [J].
BLEEHEN, NM .
BRITISH MEDICAL BULLETIN, 1973, 29 (01) :54-58
[3]  
BUSCHKE F, 1972, RADIATION THERAPY CA
[4]  
CREAVEN PJ, 1974, 58 CAN CHEM REP, P393
[5]   ANTITUMOUR ACTIVITY IN A SERIES OF BISDIKETOPIPERAZINES [J].
CREIGHTON, AM ;
HELLMANN, K ;
WHITECROSS, S .
NATURE, 1969, 222 (5191) :384-+
[6]   CLINICAL USE OF RADIATION SENSITIZING AGENTS [J].
GOFFINET, DR ;
BAGSHAW, MA .
CANCER TREATMENT REVIEWS, 1974, 1 (01) :15-26
[7]   CUMULATIVE CYTOSTATIC EFFECT OF ICRF-159 [J].
HALLOWES, RC ;
WEST, DG ;
HELLMANN, K .
NATURE, 1974, 247 (5441) :487-490
[8]  
HARE HF, 1963, CANCER, V16, P1332, DOI 10.1002/1097-0142(196310)16:10<1332::AID-CNCR2820161014>3.0.CO
[9]  
2-Z
[10]  
HELLMANN K, IN PRESS